Related Experiment Video
Updated: May 2, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
Mitofusins: ubiquitylation promotes fusion
1Institute for Genetics, Centre for Molecular Medicine (CMMC), Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Zülpicher Str 47a, 50674 Cologne, Germany.
Abstract:
Mitochondrial genes including Mfn2 are at the center of many diseases, underscoring their potential as a therapeutical target. The Chen group now identified 15-oxospiramilactone as a chemical inhibitor of the mammalian deubiquitylase USP30, acting on Mfn1 and Mfn2.
Insights
Researchers found 15-oxospiramilactone inhibits USP30, a deubiquitylase impacting mitochondrial proteins Mfn1 and Mfn2. This discovery highlights potential therapeutic targets for diseases linked to mitochondrial gene dysfunction.
Area of Science:
- Mitochondrial biology
- Molecular genetics
- Drug discovery
Background:
- Mitochondrial genes, such as Mitofusin 2 (Mfn2), are implicated in various diseases.
- Dysfunctional mitochondria are linked to numerous pathological conditions, making them a key research area.
- Deubiquitylases (DUBs) play critical roles in protein regulation, including mitochondrial dynamics.
Purpose of the Study:
- To identify novel chemical inhibitors targeting deubiquitylases involved in mitochondrial function.
- To explore the therapeutic potential of targeting USP30 for diseases associated with mitochondrial dysfunction.
- To investigate the effects of small molecules on mitochondrial proteins Mfn1 and Mfn2.
Main Methods:
- Chemical screening to identify inhibitors of mammalian deubiquitylase USP30.
- Biochemical assays to confirm the inhibitory activity of 15-oxospiramilactone.
- Analysis of the effects of the inhibitor on mitochondrial proteins Mfn1 and Mfn2.
Main Results:
- 15-oxospiramilactone was identified as a chemical inhibitor of the deubiquitylase USP30.
- The inhibitor was shown to act on mammalian Mitofusin 1 (Mfn1) and Mitofusin 2 (Mfn2).
- This finding establishes a link between USP30 inhibition and modulation of key mitochondrial proteins.
Conclusions:
- 15-oxospiramilactone is a novel inhibitor of USP30, impacting Mfn1 and Mfn2.
- Targeting USP30 with small molecules like 15-oxospiramilactone presents a potential therapeutic strategy.
- Further research into USP30 inhibitors could lead to new treatments for mitochondrial-related diseases.
Related Concept Videos
Tagging and Fusion Proteins
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
SNAREs and Membrane Fusion
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

